Galactosilated dopamine increases attention without reducing activity in C57BL/6 mice

Behavioural Brain Research

Volumn 187, Issue 2, 2008, Pages 449-454

  Ruocco, L A ^a   Viggiano, D ^a   Pignatelli, M ^a   Iannaccone, T ^a   Rimoli, M G ^a   Melisi, D ^a   Curcio, A ^a   De Lucia, S ^a   Carboni, E ^b   Carnevale, U A Gironi ^a   de Caprariis, P ^c   Sadile, A G ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

Author keywords

ADHD; Genetic models; Prodrug

Indexed keywords

DOPAMINE; GALACTOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION DEFICIT DISORDER; C57BL 6 MOUSE; CHEMICAL REACTION; COGNITION; CONTROLLED STUDY; FEMALE; GALACTOSYLATION; INBRED STRAIN; MALE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANIMALS; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DISEASE MODELS, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; FEMALE; GALACTOSE; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; SPECIES SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 38049055897     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2007.10.007     Document Type: Article

References (34)

1. Amara S.G., and Arriza J.L. Neurotransmitter transporters: three distinct gene families. Curr Opin Neurobiol 3 (1993) 337-344
2. Aspide R., Fresiello A., De Filippis G., Gironi Carnevale U.A., and Sadile A.G. Non-selective attention in a rat model of hyperactivity and attention deficit: subchronic methylphenidate and nitric oxide synthesis inhibitor treatment. Neurosci Biobehav Rev 24 (2000) 59-71
3. Aspide R., Gironi Carnevale U.A., Sergeant J.A., and Sadile A.G. Non-selective attention and nitric oxide in putative animal models of attention-deficit hyperactivity disorder. Behav Brain Res 95 (1998) 123-133
4. Bevins R.A., and Besheer J. Novelty reward as a measure of anhedonia. Neurosci Biobehav Rev 29 (2005) 707-714
5. Bonina F., Puglia C., Rimoli M.G., Melisi D., Boatto G., Nieddu M., et al. Glycosyl derivatives of dopamine and L-dopa as anti-Parkinson prodrugs: synthesis, pharmacological activity and in vitro stability studies. J Drug Target 11 (2003) 25-36
6. Broadhurst P.L. Experiments in psychogenetics: application of biometrical genetics to the inheritance of behaviour. In: Eysenck H.J. (Ed). Experiments in personality. Psychogenetics and psychopharmacology vol. I (1960), Routledge, Regan Paul, London 1-102
7. Cabib S. The contribution of comparative studies in inbred strains of mice to the understanding of the hyperactive phenotype. Behav Brain Res (2002)
8. Cabib S., Giardino L., Calza L., Zanni M., Mele A., and Puglisi-Allegra S. Stress promotes major changes in dopamine receptor densities within the mesoaccumbens and nigrostriatal systems. Neuroscience 84 (1998) 193-200
9. Dalpiaz A., Filosa R., De Caprariis P., Conte G., Bortolotti F., Biondi C., et al. Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate. Int J Pharm 336 (2007) 133-139
10. de Souza Silva M.A., Topic B., Huston J.P., and Mattern C. Intranasal dopamine application increases dopaminergic activity in the neostriatum and nucleus accumbens and enhances motor activity in the open field. Synapse (2007)
11. Everitt B.J., and Robbins T.W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8 (2005) 1481-1489
12. Faraone S.V., Sergeant J., Gillberg C., and Biederman J. The worldwide prevalence of ADHD: is it an American condition?. World Psychiatry 2 (2003) 104-113
13. Grace A.A., Bunnney B.S., Moore H., and Todd C.L. Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs. Trends Neurosci 20 (1997) 31-37
14. Grillner P., and Mercuri N.B. Intrinsic membrane properties and synaptic inputs regulating the firing activity of the dopamine neurons. Behav Brain Res 130 (2002) 149-169
15. Hölm S. A simple sequentially rejective multiple test procedure. Scand J Stat 6 (1979) 65-70
16. Hooks M.S., and Kalivas P.W. Involvement of dopamine and excitatory amino acid transmission in novelty-induced motor activity. J Pharmacol Exp Ther 269 (1994) 976-988
17. Imperato A., and Di Chiara G. Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis. Eur J Pharmacol 156 (1988) 385-393
18. Kempf F., Brucke C., Kuhn A.A., Schneider G.H., Kupsch A., Chen C.C., et al. Modulation by dopamine of human basal ganglia involvement in feedback control of movement. Curr Biol 17 (2007) R587-R589
19. Kiyatkin E.A. Dopamine in the nucleus accumbens: cellular actions, drug- and behavior-associated fluctuations, and a possible role in an organism's adaptive activity. Behav Brain Res 137 (2002) 27-46
20. Krain A.L., and Castellanos F.X. Brain development and ADHD. Clin Psychol Rev 26 (2006) 433-444
21. Lindvall O., and Bjorklund A. The organization of ascending catecholamine neuron systems in the rat brain as revealed by glyoxylic acid fluorescence method. Histochemistry 39 (1974) 97-127
22. Mortensen O.V., and Amara S.G. Dynamic regulation of the dopamine transporter. Eur J Pharmacol 479 (2003) 159-170
23. Oberlin B.G., Alford J.L., and Marrocco R.T. Normal attention orienting but abnormal stimulus alerting and conflict effect in combined subtype of ADHD. Behav Brain Res 165 (2005) 1-11
24. Potter A.S., Newhouse P.A., and Bucci D.J. Central nicotinic cholinergic systems: a role in the cognitive dysfunction in attention-deficit/hyperactivity disorder?. Behav Brain Res 175 (2006) 201-211
25. Reuter M., Peters K., Schroeter K., Koebke W., Lenardon D., Bloch B., et al. The influence of the dopaminergic system on cognitive functioning: a molecular genetic approach. Behav Brain Res 164 (2005) 93-99
26. Robbins T.W., and Everitt B.J. Neurobehavioural mechanisms of reward and motivation. Curr Opin Neurobiol 6 (1996) 228-236
27. Ruocco L.A., Viggiano D, Viggiano A, Abignente E., Rimoli M.G., Melisi D, et al. Galactosilated dopamine enters into the brain, blocks mesocorticolimbic system and modulates activity and scanning time in Naples High Excitability Rats. Neuroscience in press.
28. Sergeant J.A., Geurts H., Huijbregts S., Scheres A., and Oosterlaan J. The top and the bottom of ADHD: a neuropsychological perspective. Neurosci Biobehav Rev 27 (2003) 583-592
29. Sidlo Z., Reggio P.H., and Rice M.E. Inhibition of striatal dopamine release by CB1 receptor activation requires nonsynaptic communication involving GABA, H(2)O(2), and K(ATP) channels. Neurochem Int (2007)
30. Souza Silva M.A., Mattern C., Hacker R., Nogueira P.J., Huston J.P., and Schwarting R.K. Intranasal administration of the dopaminergic agonists L-DOPA, amphetamine, and cocaine increases dopamine activity in the neostriatum: a microdialysis study in the rat. J Neurochem 68 (1997) 233-239
31. Viggiano D., Ruocco L.A., and Sadile A.G. Dopamine phenotype and behaviour in animal models: in relation to attention deficit hyperactivity disorder. Neurosci Biobehav Rev 27 (2003) 623-637
32. Viggiano D., Vallone D., Ruocco L.A., and Sadile A.G. Behavioural, pharmacological, morpho-functional molecular studies reveal a hyperfunctioning mesocortical dopamine system in an animal model of attention deficit and hyperactivity disorder. Neurosci Biobehav Rev 27 (2003) 683-689
33. Viggiano D., Vallone D., and Sadile A.G. Dysfunctions in the dopamine systems and ADHD: evidences from animals and modeling. Neural Plast 11 (2004) 93-116
34. Wong A.H., and Van Tol H.H. Schizophrenia: from phenomenology to neurobiology. Neurosci Biobehav Rev 27 (2003) 269-306